Showing results (41-50 of 12,098) with videos related to
Sort By:
Pageof 1,210
Klinische Monatsblatter Fur Augenheilkunde|May 7, 2014
[Treatment of diabetic macular oedema with the VEGF inhibitors ranibizumab and bevacizumab: conclusions from basic in vitro studies]G E Lang, G K Lang, H L DeisslerExperimental Eye Research|March 18, 2014
Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cellsHeidrun L Deissler, Gerhard K Lang, Gabriele E LangExperimental Eye Research|January 17, 2022
Blocking of VEGF-A is not sufficient to completely revert its long-term effects on the barrier formed by retinal endothelial cellsHeidrun L Deissler, Matus Rehak, Catharina Busch, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 10, 2015
Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cellsHeidrun L Deissler, Gerhard K Lang, Gabriele E LangExperimental Eye Research|October 21, 2015
Internalization of bevacizumab by retinal endothelial cells and its intracellular fate: Evidence for an involvement of the neonatal Fc receptorHeidrun L Deissler, Gerhard K Lang, Gabriele E LangCellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|July 19, 2017
Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165Heidrun L Deissler, Gerhard K Lang, Gabriele E LangGraefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|October 28, 2018
Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradationHeidrun L Deissler, Gerhard K Lang, Gabriele E LangKlinische Monatsblatter Fur Augenheilkunde|November 14, 2014
[Basic in vitro studies on VEGF inhibition with aflibercept: similarities and differences to other VEGF-binding therapeutic proteins]G E Lang, G K Lang, H L DeisslerPhysical Review Letters|December 20, 2014
Probing the axis alignment of an ultracold spin-polarized Rb(2) moleculeMarkus Deiss, Björn Drews, Benjamin Deissler, et al.Scientific Reports|July 21, 2022
Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitroHeidrun L Deissler, Catharina Busch, Armin Wolf, et al.Pageof 1,210